Prokidney to participate in the jefferies global healthcare conference

Winston-salem, n.c., may 29, 2024 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced that senior members of the management team will be participating in the jefferies global healthcare conference taking place from june 4 – 6, 2024 in new york, ny.

PROK Ratings Summary

PROK Quant Ranking